Real-World Study of the Safety and Efficacy of Surufatinib in the Treatment of Neuroendocrine Tumors

Clinical trial NCT07780539 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07780539
Sponsor: Yefeng
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Neuroendocrine (NE) Tumors

Start date: 2026-09-01
Primary completion: 2028-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.